Xiangqiang Liu
- Molecular Biology
- Cancer Research top 10%
- Accounting top 5%
- Oncology
- Finance top 5%
- Topics
- Corporate Finance and Governance (5 papers)Corporate Social Responsibility Reporting (4 papers)FOXO transcription factor regulation (3 papers)
- Cited by
- Cancer ResearchAccountingFinance
- Partner nations
- ChinaUnited StatesTaiwan
In The Last Decade
Xiangqiang Liu
18 papers receiving 685 citations
Hit Papers
Peers
Comparison fields: 5 of 82
- Molecular Biology 378
- Cancer Research 274
- Accounting 136
- Oncology 122
- Finance 98
Countries citing papers authored by Xiangqiang Liu
This map shows the geographic impact of Xiangqiang Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiangqiang Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiangqiang Liu more than expected).
Fields of papers citing papers by Xiangqiang Liu
This network shows the impact of papers produced by Xiangqiang Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiangqiang Liu. The network helps show where Xiangqiang Liu may publish in the future.
Co-authorship network of co-authors of Xiangqiang Liu
This figure shows the co-authorship network connecting the top 25 collaborators of Xiangqiang Liu. A scholar is included among the top collaborators of Xiangqiang Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiangqiang Liu. Xiangqiang Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 5 | |
| 2 | 3 | |
| 3 | 11 | |
| 4 | ESG rating disagreement and analyst forecast qualitybreakdown → | 50 |
| 5 | 19 | |
| 6 | 34 | |
| 7 | 37 | |
| 8 | 26 | |
| 9 | 49 | |
| 10 | 4 | |
| 11 | 112 | |
| 12 | 87 | |
| 13 | 15 | |
| 14 | 50 | |
| 15 | 41 | |
| 16 | 18 | |
| 17 | 120 | |
| 18 | [Expression and clinical significance of FOX04 in colorectal cancer]. | 8 |
About Xiangqiang Liu
Xiangqiang Liu is a scholar working on Accounting, Finance and Immunology and Allergy, having authored 18 papers that have together received 689 indexed citations. Recurring topics across this work include Corporate Finance and Governance (5 papers), Corporate Social Responsibility Reporting (4 papers) and FOXO transcription factor regulation (3 papers). The work is most often cited by research in Cancer Research (274 citations), Accounting (136 citations) and Finance (98 citations). Xiangqiang Liu has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Daiming Fan, Yongzhan Nie, Li Sun, Kaichun Wu, Haifeng Jin, Na Chai, Shenghao Gao, Feng Cao, Lili Liu and Zhiyong Zhang. Their work appears in journals such as Journal of Business Ethics, Carcinogenesis and Current Pharmaceutical Design.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.